eli lilly oral semaglutide 🚨 BREAKING: GLP-1 PILL BEATS NOVO NORDISK'S IN HEAD-TO-HEAD PHASE 3 DIABETES TRIAL ORFORGLIPRON DELIVERED SUPERIOR BLOOD SUGAR CONTROL & WEIGHT LOSS vs (RYBELSUS) 52-WEEK DURATION $LLY $NVO $ Lilly orforglipron oral GLP-1 phase

Some signs that your dose may need adjustment include unexpected changes in appetite or continued difficulty managing blood sugar levels

Semaglutide, originally developed for type 2 diabetes, has been recognized for its potential impact on weight

When biosimilar GLP-1 medications reach the US market, the implications will be significant: Insurance coverage will restructure Payers will likely mandate biosimilar substitution for new GLP-1 prescriptions, similar to what occurred with insulin biosimilars and adalimumab (Humira) Manufacturing access will widen Companies including Biocon, Zydus Lifesciences, and Teva are actively building production capacity

The IATA released its latest financial outlook for the airline industry over the weekend, forecasting a $98 billion jump in the sectors collective fuel bill